We read the final report of the eagerly awaited CRITICS trial1 with interest, since its overall results showed a favourable outcome when compared with the previous landmark studies, INT01162 and MAGIC.3 Population-based data suggest that the approaches established by both studies have been successfully transferred into clinical practice. The authors provide comprehensive follow-up data, including long-term renal function tests, which will be useful to observe after longer follow-up. Reassuringly, toxicity with radiochemotherapy was not excessive versus chemotherapy alone, and the conclusion by Annemieke Cats and colleagues,1 to direct research toward intensification of preoperative strategies, is reasonable.
https://ift.tt/2KwQ3Jz
Παρασκευή 29 Ιουνίου 2018
[Correspondence] Adjuvant therapy in resectable gastric cancer—the CRITICS trial
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου